ProQR Therapeutics N.V. (PRQR) vs Sionna Therapeutics, Inc. (SION)

ProQR Therapeutics N.V. and Sionna Therapeutics, Inc. are both Biotechnology companies. ProQR Therapeutics N.V. and Sionna Therapeutics, Inc. are of similar size ($241.9M and $236.1M). Sionna Therapeutics, Inc. has the higher net margin (0.00% vs −228.7%) and the lower return on invested capital (−125.0% vs 0.00%). Across the 13 metrics below, Sionna Therapeutics, Inc. leads on 9 and ProQR Therapeutics N.V. on 4.

Valuation

Metric PRQR SION Biotechnology median
P/E n/m n/m 7.88
P/S 8.45 n/m 11.47
P/B 1.96 0.89 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 2.60 n/m 10.73
Earnings yield (27.88%) (41.68%) (28.84%)
Free cash flow yield (31.63%) (32.31%) (23.03%)

Profitability

Metric PRQR SION Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin (233.33%) 0.00% 0.00%
Net margin (228.71%) 0.00% 0.00%
Free cash flow margin (267.36%) 0.00% 0.00%
Return on equity (58.29%) (32.34%) (57.72%)
Return on assets (31.53%) (30.66%) (49.22%)
Return on invested capital 0.00% (125.00%) 0.00%

Growth

Metric PRQR SION Biotechnology median
Revenue growth (TTM) 19.72% — 5.64%
EPS growth (last fiscal year) (28.57%) 88.24% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric PRQR SION Biotechnology median
Debt to equity 0.06 0.00 0.00
Current ratio 3.49 20.05 4.73
Net debt to EBITDA 2.15 2.58 0.96

Dividend

Metric PRQR SION Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric PRQR SION Biotechnology median
Market cap 236.13m 241.89m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack